Vestcor Inc’s Ibere Pharmaceuticals IBER Stock Holding History

Vestcor Inc’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$4.04M	–	1354
2022 Q4	$4.04M	Hold	400,000	–	–	0.15%	160
2022 Q3	$3.96M	Hold	400,000	–	–	0.15%	154
2022 Q2	$3.92M	Hold	400,000	–	–	0.15%	155
2022 Q1	$3.92M	Hold	400,000	–	–	0.13%	175
2021 Q4	$3.88M	Hold	400,000	–	–	0.14%	170
2021 Q3	$3.88M	Hold	400,000	–	–	0.14%	184
2021 Q2	$3.87M	Buy	+400,000	New	+$3.89M	0.13%	191

Vestcor Inc's IBER Position: Q1 2023 in Review

Vestcor Inc sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 400,000 shares — an estimated $4.04M sold.

Vestcor Inc first reported a position in IBER in Q2 2021 and held it in 7 quarters. The position peaked at $4.04M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Vestcor Inc reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Vestcor Inc sold 400,000 Ibere Pharmaceuticals shares in Q1 2023, an estimated $4.04M.
Vestcor Inc first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Vestcor Inc's Ibere Pharmaceuticals position peaked at $4.04M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Vestcor Inc's 13F filing for Q1 2023, filed 15 May 2023.